The 12 closest competitors and alternatives to Excellergy among biotechnology companies — ranked by similarity to what Excellergy actually does, not by market-cap band.
Subscribe to see Excellergy’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Excellergy is a biotechnology company developing a new therapeutic class known as Effector Cell Response Inhibitors (ECRIs) to treat severe allergic diseases. Its trifunctional mechanism aims to provide rapid and complete control of allergic responses by removing bound IgE from effector cells, neutralizing circulating free IgE, and downregulating receptor expression.
Excellergy is a biotechnology company headquartered in United States. Xcout tracks 8 named people at Excellergy, including TODD ZAVODNICK (Chief Executive Officer).
2 more named people on record for Excellergy, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to Excellergy by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Allegria Therapeutics is a Swiss biotech company founded in Basel in 2023 that targets mast cells to redefine the treatment of allergic and inflammatory diseases.
Similar biotechnology company
Alladapt Immunotherapeutics is a U.S. biotechnology company developing oral immunotherapies for food allergies. Its lead product candidate, ADP101, was designed as a single treatment intended to address multiple food allergies, serving patients with food-allergic disease.
Similar biotechnology company
IgGenix is a clinical-stage, venture-backed biotechnology company founded in 2019 and headquartered in South San Francisco, California. The company leverages its proprietary antibody discovery platform with a primary mission to cure allergies and other immunological diseases.
Similar biotechnology company
Biothea Pharma, Inc. is a pharmaceutical company developing needle-free, convenient, and cost-effective alternatives for the treatment of severe allergic reactions and anaphylaxis. The company aims to provide improved therapeutic options for patients suffering from life-threatening allergic shocks.
Life Sciences
Poplar Therapeutics is a biotechnology company focused on creating the next generation of anti-IgE medicines to treat patients. Headquartered in Cambridge, Massachusetts, the early-stage startup develops novel therapeutics to help patients live free of fear from allergic and immune conditions.
Similar biotechnology company
Allakos Inc. is a publicly traded clinical-stage biotechnology company headquartered in Redwood City, California. The company develops therapeutic antibodies that target mast cells and eosinophils to treat severe allergic, inflammatory, and proliferative diseases.
Similar biotechnology company
Aimmune Therapeutics is a U.S. biotechnology company focused on treatments for food allergies. Its lead product, Palforzia, is an oral immunotherapy for reducing allergic reactions from accidental peanut exposure in children and adolescents with peanut allergy.
Similar biotechnology company
Prota Therapeutics is a late clinical-stage biotechnology company headquartered in Melbourne, Australia, dedicated to advancing allergen oral immunotherapies for treating food allergies.
Health & Life Sciences
Holoclara is a biotechnology company headquartered in Los Angeles and Pasadena, California, pioneering the development of worm-derived therapies for allergies and inflammatory diseases.
Biotech
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Similar biotechnology company
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Similar biotechnology company
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Excellergyand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →